Venture capitalists are increasingly turning to the secondary market to purchase shares of late-stage startups, particularly those in the artificial intelligence (AI) space. This trend is driven by the desire to secure stakes in the most promising startups, but it comes with risks. One method that VCs are using to access these shares is through
AI
AI models are becoming increasingly prevalent in various industries, including the medical field. However, the outcomes of these models are often inconsistent. This inconsistency is particularly noticeable in the field of neurology, where analyzing brain scan data is crucial for diagnosing and treating brain disorders. Piramidal, a startup founded by Dimitris Sakellariou and Kris Pahuja,
Two former OpenAI researchers, Daniel Kokotajlo and William Saunders, who resigned earlier this year due to safety concerns, have expressed disappointment with OpenAI’s stance on California’s bill to prevent AI disasters, SB 1047. They believe that OpenAI is engaging in a “reckless” pursuit of dominance in the AI field, contrary to their former boss, Sam
The collaboration between Meta and Spotify has once again brought to light the challenges posed by EU regulations on open-source AI development. According to a joint statement released by both companies, the existing privacy regulations are hindering innovation in this field. Meta CEO Mark Zuckerberg and Spotify CEO Daniel Ek have raised concerns about the